Company news

Argent Biopharma Ltd news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

MXC Operational Update

December 17, 2017

New Year Launch of MGC Derma CBD Psoriasis Cream Confirmed

December 13, 2017

Binding Agreement to Supply $1m CBD Extract Annually

November 21, 2017

Definitive Supply Agreement Executed with HL Pharma

November 19, 2017

First Varm Cosmo Binding Purchase Order Received

November 14, 2017

MXC Enters Multi $M Australian Pharma Market

October 31, 2017

First $8m Binding Cosmetics Sales Agreement Signed

October 29, 2017

$40 Million White-Label CBD Cosmetics Agreement Executed

October 19, 2017

MXC Botanic Division Operational Update

October 12, 2017

Major EU Pharma Supply Agreement Signed with Lenis

October 2, 2017

Appendix 4E and Audited 2017 Financial Report

August 29, 2017

RMIT and MGC Pharmaceuticals Sign Strategic Agreement

August 23, 2017

Botanical Division Update - Europe and Australia

July 3, 2017

First European Distribution Deal Signed for API Products

June 19, 2017

EU Medical Cannabis License Granted with Strategic Agreement

June 5, 2017

Positive MGC Derma Clinical Test Results

May 22, 2017

CEO Appointment

May 10, 2017

Strategic Agreement Signed with RMIT

May 2, 2017

New EU Sales Agreements Signed For MGC Derma

May 1, 2017

Successful MXC First Cannabinoid Production

April 10, 2017

European API Extraction Facility Completed

April 5, 2017

Placement of $10m Closed Significantly Oversubscribed

March 16, 2017

Australian Legislation Changes Fast Track MXC

February 22, 2017

Cannabinoid Extraction Facility On Target Q2 Production

February 19, 2017

Medical Cannabis Clinical Study Commencing

February 13, 2017

Panax Acquisition Completed

February 6, 2017

Commencement of Dermatological Clinical Trials

January 25, 2017

European CPNP Approval Granted for Derma Products

January 8, 2017

MXC Operations Update

December 22, 2016

New Panax Acquisition Agreement Signed, Settlement Imminent

December 14, 2016

First Major European Sales and Revenue for MGC Derma Range

December 2, 2016

Cleansing Prospectus

November 9, 2016

EU Registration Commenced for CBD Derma Product Sales

November 6, 2016

September Quarter Activity and Cashflow Report

October 26, 2016

Operations Update - Multiple Revenue Streams Imminent

September 29, 2016

New Med Cannabis White Paper Developed with Uni of Sydney

September 21, 2016

Strategic Agreement signed with Epilepsy Action Australia

September 1, 2016

Appendix 4E and Audited 2016 Financial Report

August 29, 2016

Psoriasis and Acne Tests Advancing Ahead of Product Launch

August 23, 2016

Sale of Lingokoto and Bouroubourou Gold Exploration Assets

August 11, 2016

Leading Epilepsy Expert Joins MXC Strategic Advisory Board

July 13, 2016

First Revenues Received from Californian Cosmetics Deal

June 26, 2016

MXCs First Crops Planted at European CBD Production Farm

June 15, 2016

Health Canada Approves MGC Derma CBD Cosmetics

May 30, 2016

FDA Approval Granted and First US Distribution Deal Signed

May 24, 2016

Shareholder Priority Offer Closed Early - Oversubscribed

May 19, 2016

Prospectus - Priority Offer

May 16, 2016

Priority Offer Timetable - Update

May 12, 2016

Supplementary Prospectus

May 11, 2016

European Commission Approves MGC Derma Cosmetics Products

May 10, 2016

← Newer news releases · Older news releases →

Decks

The 5 newest of 10 decks. Every deck is listed under its year.